Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Delving into the topline results from the Phase 2 clinical study of RZ402 in patients with Diabetic Macular Edema (DME)

Ticker(s): RZLT

Who's the expert?

Institution: Iowa Retina Consultants

Board Certified Ophthalmologist with Iowa Retina Consultants.
Currently manages 1000 patients with Wet AMD and 500 patients for DME.
Previously served as President of the Iowa Academy of Ophthalmology and has published articles in a variety of peer-reviewed medical journals.

Interview Goal

This call will feature a discussion on the current standard of care and the potential of RZ402, an oral therapy being developed by Rezolute for the treatment of DME.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.